SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Non-Current Liabilities | ₹176 Cr | ₹123 Cr | ₹138 Cr |
What is the latest Total Non-Current Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹176 Cr |
| Mar2024 | ₹123 Cr |
| Mar2023 | ₹138 Cr |
How is Total Non-Current Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹176 Cr | 43.07 | |
| Mar2024 | ₹123 Cr | -11.15 | |
| Mar2023 | ₹138 Cr | - | |
Compare Total Non-Current Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹3,962.1 Cr | 0.9% | -9.3% | -0.4% | Stock Analytics | |
| SAGILITY INDIA | ₹18,486.6 Cr | 0.1% | -18.4% | -11.2% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,282.8 Cr | 1% | -10.6% | -39.5% | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹6,102.2 Cr | -4.2% | -29.2% | -20.7% | Stock Analytics | |
| JUST DIAL | ₹4,454.6 Cr | 0.1% | -23.3% | -35.2% | Stock Analytics | |
| AWFIS SPACE SOLUTIONS | ₹2,040.3 Cr | 5.7% | -30.2% | -60.9% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 0.9% |
-9.3% |
-0.4% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses